Literature DB >> 22026525

Alternate routes of administration and risk for HIV among prescription opioid abusers.

Hilary Surratt1, Steven P Kurtz, Theodore J Cicero.   

Abstract

Route of administration is an important contributor to the adverse health consequences of prescription medication abuse. The current study examines characteristics associated with non-oral routes of administration among a large sample of prescription opioid abusers and explores needle-related human immunodeficiency virus (HIV) risk behaviors as well. In the study, 791 opioid abusers completed a one-time structured interview, including complete histories of illicit and prescription drug abuse and route of drug administration. The most common method of pill use was oral (91%), followed by intranasal (53.1%), injection (23.8%), and smoking (14.5%). The youngest prescription opioid abusers, ages 18-24, displayed significantly higher odds of using alternate routes of administration and of reusing nonsterile needles for injection. HIV prevention programming should be developed for young prescription opioid injectors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22026525      PMCID: PMC3278771          DOI: 10.1080/10550887.2011.609805

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  14 in total

1.  Under the counter: the diffusion of narcotic analgesics to the inner city street.

Authors:  James Vivian; Hassan Saleheen; Merrill Singer; Juhem Navarro; Greg Mirhej
Journal:  J Ethn Subst Abuse       Date:  2005       Impact factor: 1.507

2.  Motives, diversion and routes of administration associated with nonmedical use of prescription opioids.

Authors:  Sean Esteban McCabe; James A Cranford; Carol J Boyd; Christian J Teter
Journal:  Addict Behav       Date:  2006-07-13       Impact factor: 3.913

Review 3.  Challenges in the development of prescription opioid abuse-deterrent formulations.

Authors:  Nathaniel P Katz; Edgar H Adams; Howard Chilcoat; Robert D Colucci; Sandra D Comer; Philip Goliber; Charles Grudzinskas; Donald Jasinski; Stephen D Lande; Steven D Passik; Sidney H Schnoll; Edward Sellers; Debra Travers; Roger Weiss
Journal:  Clin J Pain       Date:  2007-10       Impact factor: 3.442

Review 4.  Tampering with prescription opioids: nature and extent of the problem, health consequences, and solutions.

Authors:  Nathaniel Katz; Richard C Dart; Elise Bailey; Jeremiah Trudeau; Eric Osgood; Florence Paillard
Journal:  Am J Drug Alcohol Abuse       Date:  2011-04-26       Impact factor: 3.829

5.  Medical use, illicit use, and diversion of abusable prescription drugs.

Authors:  Sean Esteban McCabe; Christian J Teter; Carol J Boyd
Journal:  J Am Coll Health       Date:  2006 Mar-Apr

6.  Route of administration for illicit prescription opioids: a comparison of rural and urban drug users.

Authors:  April M Young; Jennifer R Havens; Carl G Leukefeld
Journal:  Harm Reduct J       Date:  2010-10-15

7.  Motives for nonmedical use of prescription opioids among high school seniors in the United States: self-treatment and beyond.

Authors:  Sean Esteban McCabe; Carol J Boyd; James A Cranford; Christian J Teter
Journal:  Arch Pediatr Adolesc Med       Date:  2009-08

8.  Characteristics and motives of college students who engage in nonmedical use of methylphenidate.

Authors:  Robert L Dupont; John J Coleman; Richard H Bucher; Bonnie B Wilford
Journal:  Am J Addict       Date:  2008 May-Jun

9.  Patient characteristics and risks factors for development of dependence on hydrocodone and oxycodone.

Authors:  Norman S Miller; Andrea Greenfeld
Journal:  Am J Ther       Date:  2004 Jan-Feb       Impact factor: 2.688

10.  Can abuse deterrent formulations make a difference? Expectation and speculation.

Authors:  Simon H Budman; Jill M Grimes Serrano; Stephen F Butler
Journal:  Harm Reduct J       Date:  2009-05-29
View more
  22 in total

1.  Early Initiation of Substance Use as an Indicator of Problematic Substance Use Among Young Men Who Have Sex with Men (YMSM).

Authors:  Aleksandar Kecojevic; Corey H Basch; Stephen E Lankenau
Journal:  Subst Use Misuse       Date:  2017-08-04       Impact factor: 2.164

2.  Heroin use onset among nonmedical prescription opioid users in the club scene.

Authors:  Hilary L Surratt; Steven P Kurtz; Mance Buttram; Maria A Levi-Minzi; Maria E Pagano; Theodore J Cicero
Journal:  Drug Alcohol Depend       Date:  2017-07-26       Impact factor: 4.492

3.  Assessment of a formulation designed to be crush-resistant in prescription opioid abusers.

Authors:  Suzanne K Vosburg; Jermaine D Jones; Jeanne M Manubay; Judy B Ashworth; Irma H Benedek; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2012-06-20       Impact factor: 4.492

Review 4.  Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.

Authors:  Brandon D L Marshall; Traci C Green; Jesse L Yedinak; Scott E Hadland
Journal:  Int J Drug Policy       Date:  2016-02-04

5.  Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City.

Authors:  Pedro Mateu-Gelabert; Honoria Guarino; Lauren Jessell; Anastasia Teper
Journal:  J Subst Abuse Treat       Date:  2014-07-11

6.  Prevalence and correlates of nonmedical prescription opioid use among a cohort of sex workers in Vancouver, Canada.

Authors:  Elena Argento; Jill Chettiar; Paul Nguyen; Julio Montaner; Kate Shannon
Journal:  Int J Drug Policy       Date:  2014-07-31

Review 7.  Abuse-deterrent formulations: transitioning the pharmaceutical market to improve public health and safety.

Authors:  Kyle Simon; Stacey L Worthy; Michael C Barnes; Benjamin Tarbell
Journal:  Ther Adv Drug Saf       Date:  2015-04

8.  Prevalence and Correlates of Depressive Symptomology among Young Adults Who Use Prescription Opioids Non-medically.

Authors:  Benjamin A Bouvier; Elizabeth N Kinnard; Jesse L Yedinak; Yu Li; Beth Elston; Traci C Green; Scott E Hadland; Brandon D L Marshall
Journal:  J Psychoactive Drugs       Date:  2019-08-14

9.  A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers.

Authors:  Suzanne K Vosburg; Jermaine D Jones; Jeanne M Manubay; Judy B Ashworth; Douglas Y Shapiro; Sandra D Comer
Journal:  Addiction       Date:  2013-03-13       Impact factor: 6.526

10.  Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics.

Authors:  Jon E Zibbell; Rachel Hart-Malloy; John Barry; Lillian Fan; Colleen Flanigan
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.